Ceesay Abraham
CIK 1722140
Transactions on file
26
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-15 | 2026-07-14 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,729 | $110.7K | +3.8% | open → |
| 2026-07-15 | 2026-07-14 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 5,481 | $217.7K | +6.1% | open → |
| 2026-07-01 | 2026-06-29 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 876 | $35.3K | +4.4% | open → |
| 2026-07-01 | 2026-06-29 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 7,344 | $292.1K | +5.9% | open → |
| 2026-05-11 | 2026-05-08 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Director | Grant | 1,438 | $255.4K | +26.3% | open → |
| 2025-06-04 | 2025-06-02 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Director | Grant | 946 | $127.7K | +66.1% | open → |
| 2025-06-13 | 2025-06-11 | PCRX Pacira BioSciences, Inc. | Director | Grant | 6,163 | $0.00 | — | open → |
| 2025-12-18 | 2025-12-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 515 | $16.0K | +35.7% | open → |
| 2025-12-18 | 2025-12-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,421 | $72.7K | +40.2% | open → |
| 2025-12-18 | 2025-12-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,147 | $61.9K | +46.1% | open → |
| 2025-12-18 | 2025-12-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 600 | $18.6K | +35.7% | open → |
| 2025-12-18 | 2025-12-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,792 | $83.9K | +40.2% | open → |
| 2025-12-18 | 2025-12-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,441 | $70.4K | +46.1% | open → |
| 2025-11-18 | 2025-11-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,841 | $72.3K | +65.6% | open → |
| 2025-11-18 | 2025-11-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,242 | $55.8K | +69.1% | open → |
| 2025-11-18 | 2025-11-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 3,056 | $77.7K | +65.6% | open → |
| 2025-11-18 | 2025-11-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,777 | $69.2K | +69.0% | open → |
| 2025-10-16 | 2025-10-15 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 755 | $19.8K | +61.0% | open → |
| 2025-10-16 | 2025-10-15 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 4,328 | $111.4K | +63.6% | open → |
| 2025-10-16 | 2025-10-15 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 1,186 | $31.0K | +61.2% | open → |
| 2025-10-16 | 2025-10-15 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 4,647 | $119.5K | +63.8% | open → |
| 2025-09-08 | 2025-09-04 | PCRX Pacira BioSciences, Inc. | Director | Sale | 2,354 | $64.0K | -6.3% | open → |
| 2025-09-19 | 2025-09-17 | RAPP Rapport Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 700 | $18.9K | +55.8% | open → |
| 2025-09-19 | 2025-09-17 | RAPP Rapport Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 34,885 | $917.5K | +60.2% | open → |
| 2025-09-19 | 2025-09-17 | RAPP Rapport Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 1,400 | $37.6K | +56.8% | open → |
| 2025-09-19 | 2025-09-17 | RAPP Rapport Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 39,435 | $1.04M | +60.2% | open → |
